California Awards $74.5 Million in Grants for Stem Cell Research
-
Font Size:
The grant-awarding committee was halfway through a two-day meeting, and was planning to make additional commitments Friday. Its goal in the meeting was to award $80 million. To do that, it separated all 70 proposals into three groups: those recommended for funding, proposals that could be funded if sufficient money was available, and the not recommended group. Friday, the committee considered which of the proposals in the second group will get grants.
In February, the Center for Regenerative Medicine [CIRM], as the governing body of the $3 billion initiative is known, made $45 million in SEED grants. They were given to researchers who are new to the field of stem cells. The idea behind the first round of grants was two-fold: to increase the number of researchers in stem cell work and to bring new perspectives to the field.
Typical of the grants for established researchers that were awarded yesterday was one for work spearheaded by Dr. Larry Goldstein of the University of California at San Diego. Goldstein heads the Stem Cell Initiative at UCSD, and he was a member of the group who proposed the state-wide initiative for CIRM. Goldstein’s group was awarded $2.5 million to use human embryonic stem cells to generate human neuronal models of hereditary Alzheimer's disease. The models will be used to test theories about causes and cures for AD.
CIRM began allocating money after it won an appellate court challenge to the initiative. It is expected that opponents of the initiative will take the legal battle to the California Supreme Court, but CIRM has been using donations and loans (some from the state and some from philanthropists) to get its programs underway.
The $3 billion bill approved by voters will distribute $300 million per year for 10 years.
Disclosure: none.
- Myriad Genetics, Inc. F4Q08 (Qtr End 06/30/08) Earnings Call Transcript »
- American Oriental Bioengineering, Inc. Q2 2008 Earnings Call Transcript »
- Would Genentech Be Better Off Left Alone by Roche? »
- Biotech ETFs: Can You Handle 209% Volatility? »
- AstraZeneca Gives FluMist Spray a Shot in the Arm »
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
ETFs In Focus
-
Editor's Picks
-
Most Popular
- Solvency and Liquidity: Non-Identical Twins
- The Great Inflation Debate
- Disclosure from Financials? I Call B.S.
- Financials and Housing: The Outlook Remains Ugly
- Martin Wolf on Capitalism
- Interview with Jim Rogers, Part I: Bigger Financial Shocks Loom
- Full list of Editor's Picks »
- Apple: Great Company with Lofty Valuation - Due for Pullback »
- Cramer Continues to Dig a Sirius Hole for Himself »
- The Disconnect Between Supply and Demand in Gold & Silver Markets »
- The Great Consumer Crash of 2009 »
- Wall Street Breakfast: Must-Know News »
- With Help from California, Solar Gets Fired Up »
- Don't Cancel Motorola's Funeral Just Yet »
- Forget $100 a Barrel - Oil Will Plummet to $30 »
- Petrobras: Buy and Sit Tight Like Soros »
- Time to Pull the Trigger on Four Oil Service Stocks »
- 5 Potential Buyout Targets in Biotech - Barron's »
-
Long Ideas
-
Short Ideas
-
Cramer's Picks
- Screener Picks, Part III: Three Mega-cap Long Picks
- Financial Downgrades Down Markets - Fast Money Recap (8/19/08)
- Transocean: Drilling Deep for Profits
- Whose Freddie Investment Thesis Is Right?
- Steel Dynamics: Bullish with a Share Repurchase Program
- E-Trade Financial Carries High Risk-Reward
- Interested in Bank of America? Consider the Preferred Shares
- Northgate: Mid-Tier Gold Producer with Strong Cashflow
- Toll Brothers Staying Alive - Fast Money Midday Recap (8/19/08)
- Hedge Fund Tracking: Blue Ridge Capital (John Griffin)
- Full list of Long Ideas »
- Salesforce.com: It's All About the Guidance
- Three Casino Stocks Rolling Over
- New Web Site For Short Sellers: You Gotta Love Capitalism
- Commodity Carnage: Where to Turn Next?
- Fannie and Freddie Shareholders Run for the Exit
- Goldman: Readying Short Position Initiation Sequence
- Apple: Great Company with Lofty Valuation - Due for Pullback
- Russia's Too Risky - Barron's
- Fannie, Freddie Shareholders Will Be Left Holding the Bag - Barron's
- Pilgrim's Pride: The Weakest Link in the Food Chain
- Full list of Short Ideas »
- Coke vs. Pepsi - Cramer's Mad Money (8/19/08)
- Clean Energy - Cramer's Lightning Round (8/19/08)
- Still Growing - Cramer's Mad Midday (8/19/08)
- Which Stock to Pick - Cramer's Mad Money (8/18/08)
- Buy Weyerhauser - Cramer's Lightning Round (8/18/08)
- The Price of Oil - Cramer's Mad Money (8/18/08)
- Great Execution Pick - Cramer's Mad Money (8/14/08)
- Beaten Down Buy - Cramer's Lightning Round (8/14/08)
- The Fry Guy - Cramer's Midday Mad Money (8/14/08)
- Go Orbital - Cramer's Mad Money (8/13/08)
- Full list of Cramers Picks »
Trading Center
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »


